HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
334.61
+6.99 (2.13%)
Jan 30, 2025, 4:00 PM EST - Market closed
HCA Healthcare Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 380.2, with a low estimate of 320 and a high estimate of 440. The average target predicts an increase of 13.62% from the current stock price of 334.61.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 4 | 3 | 3 | 4 |
Buy | 6 | 6 | 7 | 6 | 6 | 7 |
Hold | 5 | 6 | 6 | 5 | 5 | 4 |
Sell | 0 | 0 | 0 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 18 | 17 | 15 | 15 | 16 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $405 → $384 | Buy | Maintains | $405 → $384 | +14.76% | Jan 27, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $380 → $370 | Strong Buy | Maintains | $380 → $370 | +10.58% | Jan 27, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $405 | Buy | Reiterates | $405 | +21.04% | Jan 27, 2025 |
Barclays | Barclays | Buy Maintains $392 → $366 | Buy | Maintains | $392 → $366 | +9.38% | Jan 27, 2025 |
Keybanc | Keybanc | Buy Maintains $420 → $370 | Buy | Maintains | $420 → $370 | +10.58% | Jan 7, 2025 |
Financial Forecast
Revenue This Year
75.51B
from 70.60B
Increased by 6.94%
Revenue Next Year
79.56B
from 75.51B
Increased by 5.37%
EPS This Year
24.76
from 22.00
Increased by 12.56%
EPS Next Year
27.56
from 24.76
Increased by 11.31%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 80.1B | 85.3B | 90.2B | ||
Avg | 75.5B | 79.6B | 85.2B | ||
Low | 71.2B | 75.7B | 80.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.5% | 13.0% | 13.3% | ||
Avg | 6.9% | 5.4% | 7.0% | ||
Low | 0.8% | 0.3% | 0.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 26.79 | 30.36 | 33.16 | ||
Avg | 24.76 | 27.56 | 31.32 | ||
Low | 22.94 | 24.35 | 30.07 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.8% | 22.6% | 20.3% | ||
Avg | 12.6% | 11.3% | 13.6% | ||
Low | 4.3% | -1.7% | 9.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.